Top compounds associated with response to FBXO30


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.04
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.04
mRNA PL-DI CTRPv2 pan-cancer AAC -0.064 0.04
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.04
mRNA parbendazole CTRPv2 pan-cancer AAC 0.063 0.04
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.063 0.04
mRNA GDC-0879 CTRPv2 pan-cancer AAC -0.072 0.04
mRNA KIN001-260 GDSC1000 pan-cancer AAC 0.064 0.04
mRNA CGP-60474 GDSC1000 pan-cancer AAC 0.11 0.04
mRNA PD173074 GDSC1000 pan-cancer AAC -0.071 0.04
Download CSV